UniSa - IRIS Institutional Research Information System

IACCARINO, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.292
AS - Asia 11.191
EU - Europa 4.178
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 120
OC - Oceania 5
Totale 31.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.132
HK - Hong Kong 6.519
SG - Singapore 2.054
IT - Italia 1.619
CN - Cina 999
VN - Vietnam 720
UA - Ucraina 710
BR - Brasile 616
DE - Germania 386
RU - Federazione Russa 385
TR - Turchia 245
IE - Irlanda 230
FR - Francia 210
FI - Finlandia 183
KR - Corea 181
SE - Svezia 180
IN - India 102
BD - Bangladesh 95
GB - Regno Unito 92
AR - Argentina 60
CA - Canada 60
MX - Messico 55
JP - Giappone 41
PL - Polonia 37
IQ - Iraq 33
NL - Olanda 33
ZA - Sudafrica 33
ES - Italia 30
PK - Pakistan 27
EC - Ecuador 24
ID - Indonesia 23
EU - Europa 20
VE - Venezuela 20
UZ - Uzbekistan 19
PH - Filippine 17
AT - Austria 16
MY - Malesia 16
SA - Arabia Saudita 16
JO - Giordania 15
KE - Kenya 14
PY - Paraguay 14
TN - Tunisia 14
CL - Cile 12
CO - Colombia 12
CZ - Repubblica Ceca 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
MA - Marocco 9
CH - Svizzera 8
EG - Egitto 7
NP - Nepal 7
AL - Albania 6
BO - Bolivia 6
CR - Costa Rica 6
HN - Honduras 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
KG - Kirghizistan 5
LT - Lituania 5
AO - Angola 4
BE - Belgio 4
CI - Costa d'Avorio 4
GR - Grecia 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
GE - Georgia 3
GH - Ghana 3
LU - Lussemburgo 3
MK - Macedonia 3
NI - Nicaragua 3
OM - Oman 3
TT - Trinidad e Tobago 3
BB - Barbados 2
GY - Guiana 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
YT - Mayotte 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
Totale 30.557
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.506
Ann Arbor 2.883
Wilmington 2.394
Singapore 1.086
San Jose 955
Jacksonville 884
Woodbridge 855
Chandler 846
Princeton 691
Milan 588
Houston 578
Dallas 456
Ashburn 455
Dong Ket 307
Dublin 230
Council Bluffs 219
Beijing 210
The Dalles 210
Izmir 205
Lauterbourg 185
Rome 160
Nanjing 159
Andover 158
Boardman 158
Pellezzano 138
Ho Chi Minh City 136
Mestre 135
Moscow 124
Los Angeles 109
Dearborn 97
Santa Clara 91
Salerno 90
Hanoi 89
Munich 88
Düsseldorf 80
New York 79
Fairfield 71
São Paulo 59
Changsha 56
Shenyang 53
Figino 45
Hebei 44
Falls Church 42
Nanchang 42
Memphis 40
Tokyo 40
Turin 39
Orem 37
Jiaxing 32
Saint Petersburg 32
Warsaw 32
Napoli 31
Norwalk 31
Brooklyn 28
Montreal 27
San Francisco 27
San Diego 26
Mexico City 25
Turku 25
Denver 24
Naples 24
Tianjin 24
Rio de Janeiro 23
Venezia 23
Johannesburg 22
London 22
Phoenix 21
Atlanta 20
Frankfurt am Main 20
Nuremberg 20
Stockholm 19
Jinan 18
Manchester 18
Chennai 17
Columbus 17
Grevenbroich 17
Redwood City 17
Tashkent 17
Da Nang 16
Haiphong 16
Washington 16
Cambridge 15
Charlotte 15
Chicago 15
Guangzhou 15
Pune 15
Shanghai 14
Buffalo 13
Poplar 13
Seattle 13
Amman 12
Amsterdam 12
Baghdad 12
Biên Hòa 12
Nairobi 12
Seoul 12
Curitiba 11
Helsinki 11
Lappeenranta 11
Mumbai 11
Totale 24.193
Salva come PNG Salva come JPEG
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 893
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 860
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 577
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 525
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 501
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 437
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 437
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 309
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 307
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 307
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 305
Adrenergic signaling in heart failure and cardiovascular aging 293
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 282
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 276
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 260
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 257
Serum uric acid and left ventricular mass in essential hypertension 257
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 247
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 246
Thyroid function predicts increased cardiovascular risk 240
Characterization of a selective CaMKII peptide inhibitor 227
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 224
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 222
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 213
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 213
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 212
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 211
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 205
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 205
AKT participates in endothelial dysfunction in hypertension. 197
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 197
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 197
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 194
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 189
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 188
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 186
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 181
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 181
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 173
Targeting myocardial remodelling to develop novel therapies for heart failure 172
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 171
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 170
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 169
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 167
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 167
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 166
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 166
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 166
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 162
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 162
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 162
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 161
Active and Healthy Ageing and Independent Living 2016 161
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 160
Active and Healthy Ageing and Independent Living 159
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 159
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 159
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 156
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 155
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 155
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 153
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 153
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 153
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 152
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 151
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 151
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 148
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 148
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 147
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 147
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 145
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 144
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 142
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 141
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 141
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 141
External support modulates G protein expression and receptor coupling in experimental vein grafts. 140
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 140
Good at Heart: Preserving Cardiac Metabolism during aging 140
Insufficient control of blood pressure and incident diabetes. 139
CaMK4 Gene Deletion Induces Hypertension 139
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 139
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 137
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 137
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 136
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 136
Atrial fibrillation and microRNAs 136
G Protein-Coupled Receptor Kinases and Hypertension 135
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 135
CaMKII protects MKP-1 from proteasome degradation in endothelial cells. 135
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 134
The mechanisms of air pollution and particulate matter in cardiovascular diseases 134
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 134
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 134
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 133
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 132
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 132
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 131
Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts 130
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 129
Totale 20.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.233 0 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/202613.908 1.316 3.436 2.799 475 955 551 1.471 316 505 822 266 996
2026/2027339 314 25 0 0 0 0 0 0 0 0 0 0
Totale 31.029